Ep. 15 - GLP1 Breakthroughs and Real Results
Manage episode 497219513 series 3635298
In this episode of The Scalpel’s Edge, Dr. Tim Sayed breaks down compelling new research on GLP1 medications like semaglutide, tirzepatide, and the latest entrant, ecnoglutide. With real-world data from Cleveland Clinic and insights from an international Phase 3 trial, Dr. Sayed explores how these medications are performing outside of clinical trials, what happens after patients stop taking them, and why cost, side effects, and genetic profiles may impact their effectiveness.
As a board-certified plastic surgeon who has personally used these medications, Dr. Sayed shares clinical insight, practical considerations, and where innovation in weight loss treatment is headed next. If you're curious about the future of GLP1s, their metabolic benefits, and what it means for real patients, this one’s for you.
Contact Dr. Tim Sayed:
Phone: (858) 247-2933
Email: [email protected]
Website: timsayedmd.com
Instagram: @timsayedmd
YouTube: @Timsayedmd
Facebook: Tim Sayed MD
16 episodes